Executive Summary
A comprehensive research report created through extensive primary research (inputs from industry experts, companies, stakeholders) and secondary research, the report aims to present the analysis of Global HPV Vaccine Market by End-User (Male and Female), By Age-Group (Adolescent and Adults), By Region (North America, Europe, Asia Pacific, Rest of the world) and By Country (U.S., Canada, United Kingdom, Germany, France, Japan China, India).
According to Azoth Analytics research report "Global HPV Vaccine Market: Analysis By End-User (Male, Female), By Age Group (Adolescents, Adults) - By Region, By Country (2017-2022) - By Region (North America, Europe, APAC and RoW), By Country (US, Canada, UK, Germany, France, China, India, Japan)", the global market is projected to display a robust growth represented by a CAGR of 4.18% during 2017 - 2022.
The segment of Female HPV vaccine market witnessed growth at a noteworthy rate over the past few years and is expected to grow in the forecast period on the back of rising awareness regarding HPV related fatal diseases, rising healthcare expenditures along with rising disposable incomes. Amongst the regions, North America accounts for the largest regional share in the global HPV vaccine market in 2017. Key factors driving the robust growth rate of North America region include emergence of second generation of HPV vaccines with lower dosage schedule and increasing HPV vaccination recommendation for male adolescents and adult population, increasing number of patients diagnosed with anogenital and oropharynx cancers as well as rising prevalence of HPV virus.
The report titled "Global HPV Vaccine Market: Analysis By End-User (Male, Female), By Age Group (Adolescents, Adults) - By Region, By Country (2017-2022) - By Region (North America, Europe, APAC and RoW), By Country (US, Canada, UK, Germany, France, China, India, Japan)" has covered and analysed the potential of Global HPV Vaccine Market and provides statistics and information on market size, shares and growth factors. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment evaluation. Besides, the report also identifies and analyses the emerging trends along with major drivers, challenges and opportunities in the global HPV vaccine market. Additionally, the report also highlights market entry strategies for various companies across the globe.
Scope of the Report
Global HPV Vaccine Market (Actual Period: 2012-2016, Forecast Period: 2017-2022
• Global HPV Vaccine Market - Size and Growth
• By End User - Male and Female
• By Age Group - Adolescent and Adults
Regional Markets - North America, Europe, Asia-Pacific and Rest of the World (Actual Period: 2012-2016, Forecast Period: 2017-2022)
• HPV Vaccine Market - Size and Growth
• By End User - Male and Female
• By Age Group - Adolescent and Adults
Country Analysis - U.S., Canada, United Kingdom, Germany, France, Japan, China, India
• HPV vaccine Market - Size and Growth
• By End User - Male and Female
Other Report Highlights
• Market Dynamics - Drivers and Restraints
• Market Trends
• Porter Five Force Analysis
• Policy and Regulatory Landscape
• Company Analysis - Merck and Co,, GlaxoSmithKline
Customization of the Report
The report could be customized according to the client's specific research requirements. No additional cost will be required to pay for limited additional research.
Table of Content 1. Research Methodology 2. Executive Summary 3. Strategic Recommendations 4. HPV Vaccine Market: Product Outlook 5. Global HPV Vaccine Market: Growth and Forecast 5.1. Global HPV Vaccine Market, By Value (2012-2016) 5.2. Global HPV Vaccine Market, By Value (2017-2022) 5.3. Global HPV Vaccine Market - By End-User, By Value 5.3.1. Global HPV Vaccine Market, By Value, % (2016) 5.3.2. Global HPV Vaccine Market, By Value, % (Forecast 2022F) 5.4. Global HPV Vaccine Market, By End-User, By Value (2012-2022) 5.4.1. Male, By Value (2012-2022) 5.4.2. Female, By Value (2012-2022) 5.5. Global HPV Vaccine Market, By Age-Group, By Value (2012-2022) 5.5.1. Adolescent, By Value (2012-2022) 5.5.2. Adult, By Value (2012-2022) 6. North America HPV Vaccine Market: Growth and Forecast 6.1. North America HPV Vaccine Market, By Value (2012-2016) 6.2. North America HPV Vaccine Market, By Value (2017-2022) 6.3. North America HPV Vaccine Market - By End-User, By Value 6.3.1. North America HPV Vaccine Market, By Value, % (2016) 6.3.2. North America HPV Vaccine Market, By Value, % (Forecast 2022F) 6.4. North America HPV Vaccine Market, By End-User, By Value (2012-2022) 6.4.1. Male, By Value (2012-2022) 6.4.2. Female, By Value (2012-2022) 6.5. North America HPV Vaccine Market, By Age-Group, By Value (2012-2022) 6.5.1. Adolescent, By Value (2012-2022) 6.5.2. Adult, By Value (2012-2022) 6.6. North America HPV Vaccine Market: Country Analysis (U.S., Canada) 6.6.1. North America HPV Vaccine Market, Country Share, 2016 (% of Total) 6.6.2. North America HPV Vaccine Market, Country Share, 2022 (% of Total) 6.7. U.S. HPV Vaccine Market: Growth and Forecast 6.7.1. U.S. HPV Vaccine Market, By Value (2012-2016) 6.7.2. U.S. HPV Vaccine Market, By Value (2017-2022) 6.8. U.S. HPV Vaccine Market - By End-User, By Value 6.8.1. Male, By Value (2012-2022) 6.8.2. Female, By Value (2012-2022) 6.9. Canada HPV Vaccine Market: Growth and Forecast 6.9.1. Canada HPV Vaccine Market, By Value (2012-2016) 6.9.2. Canada HPV Vaccine Market, By Value (2017-2022) 6.10. Canada HPV Vaccine Market - By End-User, By Value 6.10.1. Male, By Value (2012-2022) 6.10.2. Female, By Value (2012-2022) 7. Europe HPV Vaccine Market: Growth and Forecast 7.1. Europe HPV Vaccine Market, By Value (2012-2016) 7.2. Europe HPV Vaccine Market, By Value (2017-2022) 7.3. Europe HPV Vaccine Market - By End-User, By Value 7.3.1. Europe HPV Vaccine Market, By Value, % (2016) 7.3.2. Europe HPV Vaccine Market, By Value, % (Forecast 2022F) 7.4. Europe HPV Vaccine Market, By End-User, By Value (2012-2022) 7.4.1. Male, By Value (2012-2022) 7.4.2. Female, By Value (2012-2022) 7.5. Europe HPV Vaccine Market, By Age-Group, By Value (2012-2022) 7.5.1. Adolescent, By Value (2012-2022) 7.5.2. Adult, By Value (2012-2022) 7.6. Europe HPV Vaccine Market: Country Analysis (U.K., Germany, France & Rest of Europe) 7.6.1. Europe HPV Vaccine Market, Country Share, 2016 (% of Total) 7.6.2. Europe HPV Vaccine Market, Country Share, 2022 (% of Total) 7.7. U.K. HPV Vaccine Market: Growth and Forecast 7.7.1. U.K. HPV Vaccine Market, By Value (2012-2016) 7.7.2. U.K. HPV Vaccine Market, By Value (2017-2022) 7.8. U.K. HPV Vaccine Market - By End-User, By Value 7.8.1. Male, By Value (2012-2022) 7.8.2. Female, By Value (2012-2022) 7.9. Germany HPV Vaccine Market: Growth and Forecast 7.9.1. Germany HPV Vaccine Market, By Value (2012-2016) 7.9.2. Germany HPV Vaccine Market, By Value (2017-2022) 7.10. Germany HPV Vaccine Market - By End-User, By Value 7.10.1. Male, By Value (2012-2022) 7.10.2. Female, By Value (2012-2022) 7.11. France HPV Vaccine Market: Growth and Forecast 7.11.1. France HPV Vaccine Market, By Value (2012-2016) 7.11.2. France HPV Vaccine Market, By Value (2017-2022) 7.12. France HPV Vaccine Market - By End-User, By Value 7.12.1. Male, By Value (2012-2022) 7.12.2. Female, By Value (2012-2022) 7.13. Rest of Europe HPV Vaccine Market: Growth and Forecast 7.13.1. Rest of Europe HPV Vaccine Market, By Value (2012-2016) 7.13.2. Rest of Europe Vaccine Market, By Value (2017-2022) 8. Asia-Pacific HPV Vaccine Market: Growth and Forecast 8.1. Asia-Pacific HPV Vaccine Market, By Value (2012-2016) 8.2. Asia-Pacific HPV Vaccine Market, By Value (2017-2022) 8.3. Asia-Pacific HPV Vaccine Market - By End-User, By Value 8.3.1. Asia-Pacific HPV Vaccine Market, By Value, % (2016) 8.3.2. Asia-Pacific HPV Vaccine Market, By Value, % (Forecast 2022F) 8.4. Asia-Pacific HPV Vaccine Market, By End-User, By Value (2012-2022) 8.4.1. Male, By Value (2012-2022) 8.4.2. Female, By Value (2012-2022) 8.5. Asia-Pacific HPV Vaccine Market, By Age-Group, By Value (2012-2022) 8.5.1. Adolescent, By Value (2012-2022) 8.5.2. Adult, By Value (2012-2022) 8.6. Asia-Pacific HPV Vaccine Market: Country Analysis (Japan, China, India) 8.6.1. Asia-Pacific HPV Vaccine Market, Country Share, 2016 (% of Total) 8.6.2. Asia-Pacific HPV Vaccine Market, Country Share, 2022 (% of Total) 8.7. Japan HPV Vaccine Market: Growth and Forecast 8.7.1. Japan HPV Vaccine Market, By Value (2012-2016) 8.7.2. Japan HPV Vaccine Market, By Value (2017-2022) 8.8. Japan HPV Vaccine Market - By End-User, By Value 8.8.1. Male, By Value (2012-2022) 8.8.2. Female, By Value (2012-2022) 8.9. China HPV Vaccine Market: Growth and Forecast 8.9.1. China HPV Vaccine Market, By Value (2012-2016) 8.9.2. China HPV Vaccine Market, By Value (2017-2022) 8.10. China HPV Vaccine Market - By End-User, By Value 8.10.1. Male, By Value (2012-2022) 8.10.2. Female, By Value (2012-2022) 8.11. India HPV Vaccine Market: Growth and Forecast 8.11.1. India HPV Vaccine Market, By Value (2012-2016) 8.11.2. India HPV Vaccine Market, By Value (2017-2022) 8.12. India HPV Vaccine Market - By End-User, By Value 8.12.1. Male, By Value (2012-2022) 8.12.2. Female, By Value (2012-2022) 9. ROW HPV Vaccine Market: Growth and Forecast 9.1. ROW HPV Vaccine Market, By Value (2012-2016) 9.2. ROW HPV Vaccine Market, By Value (2017-2022) 10. Market Dynamics 10.1. Increasing healthcare awareness about Sexually Transmissible Disease 10.2. Development of Healthcare Infrastructure 10.3. Rising global healthcare expenditure and favorable reimbursed policies 11. Market Restraints 12. Market Trends 13. SWOT Analysis - HPV Vaccine Market 14. Porter's Five Forces Analysis 15. Policy and Regulatory Landscape 16. Company Profiles 16.1. Merck and Co 16.2. GlaxoSmithKline 17. About Us
| Price : US$ 2450 | Date : Apr 2024 |
| Category : Manufacturing and Construction | Pages : 260 |
| Price : US$ 3500 | Date : Dec 2023 |
| Category : Medical Devices | Pages : 174 |
| Price : US$ 3500 | Date : Dec 2023 |
| Category : Medical Devices | Pages : 109 |
| Price : US$ 2600 | Date : Nov 2023 |
| Category : Healthcare and Pharmaceuticals | Pages : 141 |
| Price : US$ 2600 | Date : Nov 2023 |
| Category : Healthcare and Pharmaceuticals | Pages : 142 |
We will be happy to help you find what you need. Please call us or write to us:
Want us to send you latest updates of the current trends, insights, and more, signup to our newsletter (for alerts, special offers, and discounts).
This website is secured Origin CA certificate on the server, Comodo, Firewall and Verified Sitelock Malware Protection
Request Sample 
Request Discount 
Inquire Before Buy
